These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1949893)
1. New metabolites of the drug 5-aminosalicylic acid. II. N-formyl-5-aminosalicylic acid. Tjørnelund J; Hansen SH; Cornett C Xenobiotica; 1991 May; 21(5):605-12. PubMed ID: 1949893 [TBL] [Abstract][Full Text] [Related]
2. New metabolites of the drug 5-aminosalicylic acid. I: N-beta-D-glucopyranosyl-5-aminosalicylic acid. Tjørnelund J; Hansen SH; Cornett C Xenobiotica; 1989 Aug; 19(8):891-9. PubMed ID: 2815831 [TBL] [Abstract][Full Text] [Related]
3. High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma. Nobilis M; Vybíralová Z; Sládková K; Lísa M; Holcapek M; Kvetina J J Chromatogr A; 2006 Jun; 1119(1-2):299-308. PubMed ID: 16466733 [TBL] [Abstract][Full Text] [Related]
4. Stability of 5-aminosalicylic acid and its metabolites in plasma at -20 degrees C. Formation of N-beta-D-glucopyranosyl-5-aminosalicylic acid. Tjørnelund J; Hansen SH J Chromatogr; 1991 Sep; 570(1):224-8. PubMed ID: 1797831 [TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers. Sandborn WJ; Hanauer SB; Buch A Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198 [TBL] [Abstract][Full Text] [Related]
6. A validated HPLC method with electrochemical detection for simultaneous assay of 5-aminosalicylic acid and its metabolite in human plasma. Palumbo G; Bacchi S; Primavera L; Palumbo P; Carlucci G Biomed Chromatogr; 2005 Jun; 19(5):350-4. PubMed ID: 15586374 [TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic assay of 5-aminosalicylic acid (5-ASA) and its metabolites N-beta-D-glucopyranosyl-5-ASA, N-acetyl-5-ASA, N-formyl-5-ASA and N-butyryl-5-ASA in biological fluids. Tjørnelund J; Hansen SH J Chromatogr; 1991 Sep; 570(1):109-17. PubMed ID: 1797816 [TBL] [Abstract][Full Text] [Related]
8. Purification and 1H NMR spectroscopic characterization of phase II metabolites of tolfenamic acid. Sidelmann UG; Christiansen E; Krogh L; Cornett C; Tjørnelund J; Hansen SH Drug Metab Dispos; 1997 Jun; 25(6):725-31. PubMed ID: 9193874 [TBL] [Abstract][Full Text] [Related]
9. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine. Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931 [TBL] [Abstract][Full Text] [Related]
10. Experimental studies on the pharmacokinetics and toxicity of 5-aminosalicylic acid-O-sulfate following local and systemic application. Herzog R; Leuschner J Arzneimittelforschung; 1995 Mar; 45(3):300-3. PubMed ID: 7741789 [TBL] [Abstract][Full Text] [Related]
11. Isolation and structure elucidation of urinary metabolites of mitoxantrone. Blanz J; Mewes K; Ehninger G; Proksch B; Greger B; Waidelich D; Zeller KP Cancer Res; 1991 Jul; 51(13):3427-33. PubMed ID: 2054783 [TBL] [Abstract][Full Text] [Related]
12. Steady state disposition of 5-aminosalicyclic acid following oral dosing. Klotz U; Stracciari GL Arzneimittelforschung; 1993 Dec; 43(12):1357-9. PubMed ID: 8141827 [TBL] [Abstract][Full Text] [Related]
13. Colorimetric determination of 5-aminosalicylic acid and its N-acetylated metabolite on urine and feces. Pieniaszek HJ; BatesTR Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):571-81. PubMed ID: 747 [TBL] [Abstract][Full Text] [Related]
14. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission. Ewe K; Becker K; Ueberschaer B Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS). Cai QX; Zhu KJ; Chen D; Gao LP Eur J Pharm Biopharm; 2003 Mar; 55(2):203-8. PubMed ID: 12637098 [TBL] [Abstract][Full Text] [Related]
16. Validation of a LC method for the determination of 5-aminosalicylic acid and its metabolite in plasma and urine. Bystrowska B; Nowak J; Brandys J J Pharm Biomed Anal; 2000 Mar; 22(2):341-7. PubMed ID: 10719917 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis. Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235 [TBL] [Abstract][Full Text] [Related]
18. Acyltransferase-mediated binding of N-hydroxyarylamides to nucleic acids. Beland FA; Allaben WT; Evans FE Cancer Res; 1980 Mar; 40(3):834-40. PubMed ID: 7471100 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of N-methyl-N'-oxonicotinium ion, a new urinary metabolite of R-(+)-nicotine in the guinea pig. Pool WF; Houdi AA; Damani LA; Layton WJ; Crooks PA Drug Metab Dispos; 1986; 14(5):574-9. PubMed ID: 2876864 [TBL] [Abstract][Full Text] [Related]
20. Isolation, characterization and direct estimation of dazoxiben and its glucuronide from human plasma and urine. Stopher DA; Beresford AP; Kinns M; Bowen DV Xenobiotica; 1981 Dec; 11(12):849-56. PubMed ID: 7200680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]